Breaking News

📝 Become a member: STAT+ subscriber benefits

STAT

www.statnews.com/stat-plus

Subscribe to STAT+ and access exclusive benefits this month


When you're a STAT+ subscriber, you get to enjoy perks like discounts on our STAT Reports and events, free access to premium data tools like our CRISPR TRACKR, as well as in-depth daily coverage and analysis of the life sciences.

JOIN STAT+




JPM Recap, Live!

Date: January 13, 2023 from 1pm–2pm EST
Location: Virtual
Relive the return to an in-person J.P. Morgan Healthcare Conference with STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for next week.
 

Sign Up




New treatments for blood cancers, new hope for patients

Blood cancers like multiple myeloma have long been considered incurable. But in the last decade, the development of precision immunotherapy treatments has offered patients months or even years of extended life. One such treatment, known as CAR-T cell therapy, turns immune system T cells into killers of cancer cells. The articles in our latest e-book track the future potential of this game-changing approach to treatment.
 

Download


There is a simple, outright cure for hepatitis C.

But state prisons across the country are failing to save hundreds of people who die each year from the virus and related complications. STAT reporter Nicholas Florko spent two years talking to nearly 100 people, filing more than 200 public records requests, and reviewing thousands of pages of legal filings to show prisons’ blatant refusal to test and treat people with the condition. Read more from the STAT investigation: Death Sentence.

Read more


STAT+ Reads

Check out our recent top stories:

Read more

Tuesday, January 3, 2023

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2023, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments